ArticleEuropean journal of clinical pharmacology2011

CYP2C19-guided design of a proton pump inhibitor dose regimen to avoid the need for pharmacogenetic individualization in H. pylori eradication.

Michael B Ward et al.PubMed ↗Publisher ↗

No numbers read from the abstract.